Tips for Testing Adults With Suspected Genetic Kidney Disease

Am J Kidney Dis. 2024 Jun;83(6):816-824. doi: 10.1053/j.ajkd.2023.10.011. Epub 2023 Dec 24.

Abstract

Genetic kidney disease is common but often unrecognized. It accounts for most cystic kidney diseases and tubulopathies, many forms of congenital abnormalities of the kidney and urinary tract (CAKUT), and some glomerulopathies. Genetic kidney disease is typically suspected where the disease usually has a genetic basis or there is another affected family member, a young age at onset, or extrarenal involvement, but there are also many exceptions to these "rules". Genetic testing requires the patient's written informed consent. When a patient declines testing, another later conversation may be worthwhile. Genetic testing not only indicates the diagnosis but also the inheritance pattern, likely at-risk family members, disease in other organs, clinical course, and possibly effective treatments. Sometimes genetic testing does not identify a pathogenic variant even where other evidence is strong. A variant of uncertain significance (VUS) may be reported but should not be used for clinical decision making. It may be reclassified after more information becomes available without necessarily retesting the patient. Patients should be provided with a copy of their genetic test report, the results explained, and at-risk family members offered "cascade" testing. A referral to a clinical geneticist or genetic counselor helps identify affected family members and in providing advice to assist with reproductive decisions.

Keywords: At-risk family members; CAKUT; cascade testing; cystic kidney disease; genetic counseling; genetic kidney disease; genetic testing; glomerulopathy; informed consent; reproductive decisions; tubulopathy; variant of uncertain significance.

MeSH terms

  • Adult
  • Female
  • Genetic Counseling
  • Genetic Testing* / methods
  • Humans
  • Kidney Diseases* / diagnosis
  • Kidney Diseases* / genetics
  • Male